BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36259569)

  • 1. Investigation of androgen receptor-dependent alternative splicing has identified a unique subtype of lethal prostate cancer.
    Seltzer S; Giannopoulos PN; Bismar TA; Trifiro M; Paliouras M
    Asian J Androl; 2023; 25(3):296-308. PubMed ID: 36259569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RNA helicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer.
    Clark EL; Coulson A; Dalgliesh C; Rajan P; Nicol SM; Fleming S; Heer R; Gaughan L; Leung HY; Elliott DJ; Fuller-Pace FV; Robson CN
    Cancer Res; 2008 Oct; 68(19):7938-46. PubMed ID: 18829551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The RNA-binding and adaptor protein Sam68 modulates signal-dependent splicing and transcriptional activity of the androgen receptor.
    Rajan P; Gaughan L; Dalgliesh C; El-Sherif A; Robson CN; Leung HY; Elliott DJ
    J Pathol; 2008 May; 215(1):67-77. PubMed ID: 18273831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.
    Clark EL; Hadjimichael C; Temperley R; Barnard A; Fuller-Pace FV; Robson CN
    PLoS One; 2013; 8(1):e54150. PubMed ID: 23349811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the regulatory effects of synthesized antisense oligonucleotides on androgen receptor (AR) exon 3 splicing in prostate cancer cells.
    Wang L; Gong S; Zhang X; Azhar Z; Chen J
    Gene; 2023 May; 866():147330. PubMed ID: 36871670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.
    Dehm SM; Schmidt LJ; Heemers HV; Vessella RL; Tindall DJ
    Cancer Res; 2008 Jul; 68(13):5469-77. PubMed ID: 18593950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
    Marcias G; Erdmann E; Lapouge G; Siebert C; Barthélémy P; Duclos B; Bergerat JP; Céraline J; Kurtz JE
    Hum Mutat; 2010 Jan; 31(1):74-80. PubMed ID: 19830810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RNA-binding protein Sam68 regulates expression and transcription function of the androgen receptor splice variant AR-V7.
    Stockley J; Markert E; Zhou Y; Robson CN; Elliott DJ; Lindberg J; Leung HY; Rajan P
    Sci Rep; 2015 Aug; 5():13426. PubMed ID: 26310125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA/RNA helicase DHX9 contributes to the transcriptional program of the androgen receptor in prostate cancer.
    Chellini L; Pieraccioli M; Sette C; Paronetto MP
    J Exp Clin Cancer Res; 2022 May; 41(1):178. PubMed ID: 35590370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative splicing regulation by the androgen receptor in prostate cancer cells.
    Germain L; Lafront C; Beaudette J; Karthik Poluri RT; Weidmann C; Audet-Walsh É
    J Steroid Biochem Mol Biol; 2020 Sep; 202():105710. PubMed ID: 32534106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RELA is sufficient to mediate interleukin-1 repression of androgen receptor expression and activity in an LNCaP disease progression model.
    Thomas-Jardin SE; Dahl H; Kanchwala MS; Ha F; Jacob J; Soundharrajan R; Bautista M; Nawas AF; Robichaux D; Mistry R; Anunobi V; Xing C; Delk NA
    Prostate; 2020 Feb; 80(2):133-145. PubMed ID: 31730277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intragenic rearrangement and altered RNA splicing of the androgen receptor in a cell-based model of prostate cancer progression.
    Li Y; Alsagabi M; Fan D; Bova GS; Tewfik AH; Dehm SM
    Cancer Res; 2011 Mar; 71(6):2108-17. PubMed ID: 21248069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
    Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
    Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The mechanisms of prostate cancer progression through androgen receptor].
    Goto Y; Sakamoto S; Ichikawa T
    Nihon Rinsho; 2016 Jan; 74(1):55-9. PubMed ID: 26793880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.
    Vellky JE; McSweeney ST; Ricke EA; Ricke WA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28092-28101. PubMed ID: 33106406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cells.
    Shafi AA; Putluri V; Arnold JM; Tsouko E; Maity S; Roberts JM; Coarfa C; Frigo DE; Putluri N; Sreekumar A; Weigel NL
    Oncotarget; 2015 Oct; 6(31):31997-2012. PubMed ID: 26378018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AR intragenic deletions linked to androgen receptor splice variant expression and activity in models of prostate cancer progression.
    Li Y; Hwang TH; Oseth LA; Hauge A; Vessella RL; Schmechel SC; Hirsch B; Beckman KB; Silverstein KA; Dehm SM
    Oncogene; 2012 Nov; 31(45):4759-67. PubMed ID: 22266865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation.
    Duan L; Chen Z; Lu J; Liang Y; Wang M; Roggero CM; Zhang QJ; Gao J; Fang Y; Cao J; Lu J; Zhao H; Dang A; Pong RC; Hernandez E; Chang CM; Hoang DT; Ahn JM; Xiao G; Wang RT; Yu KJ; Kapur P; Rizo J; Hsieh JT; Luo J; Liu ZP
    Nucleic Acids Res; 2019 Dec; 47(22):11623-11636. PubMed ID: 31647098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling.
    Takayama KI
    Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30939845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nrdp1-mediated regulation of ErbB3 expression by the androgen receptor in androgen-dependent but not castrate-resistant prostate cancer cells.
    Chen L; Siddiqui S; Bose S; Mooso B; Asuncion A; Bedolla RG; Vinall R; Tepper CG; Gandour-Edwards R; Shi X; Lu XH; Siddiqui J; Chinnaiyan AM; Mehra R; Devere White RW; Carraway KL; Ghosh PM
    Cancer Res; 2010 Jul; 70(14):5994-6003. PubMed ID: 20587519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.